Loading…

Genome-wide expression profiling of glioblastoma using a large combined cohort

Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2018-10, Vol.8 (1), p.15104-12, Article 15104
Main Authors: Tang, Jing, He, Dian, Yang, Pingrong, He, Junquan, Zhang, Yang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353
cites cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353
container_end_page 12
container_issue 1
container_start_page 15104
container_title Scientific reports
container_volume 8
creator Tang, Jing
He, Dian
Yang, Pingrong
He, Junquan
Zhang, Yang
description Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p 
doi_str_mv 10.1038/s41598-018-33323-z
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6180049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2118311219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</originalsourceid><addsrcrecordid>eNp9kU1P3DAQhi3UClZb_kAPVSQuvQTGXxvnUgmtWkBawYWeLSd2gleJvbUTaPn1OCxsFw744tHMM-94_CL0FcMpBirOIsO8FDlgkVNKCc0fD9CMAOM5oYR82ouP0HGMa0iHk5Lh8hAdUaDAF6yYoesL43xv8gerTWb-boKJ0XqXbYJvbGddm_kmazvrq07FwfcqG-OUVVmnQmuy2veVdUan4M6H4Qv63KgumuOXe45-__p5u7zMVzcXV8vzVV5zBkNeaVGXWtdKLACYwgKAlE2FiQYwBXClNGeNqHBTCFZCs9BKpXWh4KrCnHI6Rz-2upux6o2ujRuC6uQm2F6Ff9IrK99WnL2Trb-Xi2kWK5PA9xeB4P-MJg6yt7E2Xaec8WOUBGNBMSZ4Qk_eoWs_BpfWm6iiJADp_-eIbKk6-BiDaXaPwSAnx-TWMZkck8-OycfU9G1_jV3Lqz8JoFsgppJrTfg_-wPZJzPNolc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117920032</pqid></control><display><type>article</type><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</creator><creatorcontrib>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</creatorcontrib><description>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p &lt; 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-018-33323-z</identifier><identifier>PMID: 30305647</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38/39 ; 38/61 ; 631/1647/48 ; 631/337/2019 ; Brain cancer ; Brain tumors ; Cell cycle ; Chemotherapy ; Gene expression ; Genomes ; Glioblastoma ; Humanities and Social Sciences ; Immune response ; Medical prognosis ; Molecular modelling ; multidisciplinary ; p53 Protein ; Patients ; Prognosis ; Science ; Science (multidisciplinary) ; Signal transduction ; Surgery ; Survival analysis</subject><ispartof>Scientific reports, 2018-10, Vol.8 (1), p.15104-12, Article 15104</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</citedby><cites>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</cites><orcidid>0000-0002-4909-4939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2117920032/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2117920032?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30305647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>He, Dian</creatorcontrib><creatorcontrib>Yang, Pingrong</creatorcontrib><creatorcontrib>He, Junquan</creatorcontrib><creatorcontrib>Zhang, Yang</creatorcontrib><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p &lt; 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</description><subject>38/39</subject><subject>38/61</subject><subject>631/1647/48</subject><subject>631/337/2019</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Cell cycle</subject><subject>Chemotherapy</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Glioblastoma</subject><subject>Humanities and Social Sciences</subject><subject>Immune response</subject><subject>Medical prognosis</subject><subject>Molecular modelling</subject><subject>multidisciplinary</subject><subject>p53 Protein</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal transduction</subject><subject>Surgery</subject><subject>Survival analysis</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kU1P3DAQhi3UClZb_kAPVSQuvQTGXxvnUgmtWkBawYWeLSd2gleJvbUTaPn1OCxsFw744tHMM-94_CL0FcMpBirOIsO8FDlgkVNKCc0fD9CMAOM5oYR82ouP0HGMa0iHk5Lh8hAdUaDAF6yYoesL43xv8gerTWb-boKJ0XqXbYJvbGddm_kmazvrq07FwfcqG-OUVVmnQmuy2veVdUan4M6H4Qv63KgumuOXe45-__p5u7zMVzcXV8vzVV5zBkNeaVGXWtdKLACYwgKAlE2FiQYwBXClNGeNqHBTCFZCs9BKpXWh4KrCnHI6Rz-2upux6o2ujRuC6uQm2F6Ff9IrK99WnL2Trb-Xi2kWK5PA9xeB4P-MJg6yt7E2Xaec8WOUBGNBMSZ4Qk_eoWs_BpfWm6iiJADp_-eIbKk6-BiDaXaPwSAnx-TWMZkck8-OycfU9G1_jV3Lqz8JoFsgppJrTfg_-wPZJzPNolc</recordid><startdate>20181010</startdate><enddate>20181010</enddate><creator>Tang, Jing</creator><creator>He, Dian</creator><creator>Yang, Pingrong</creator><creator>He, Junquan</creator><creator>Zhang, Yang</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4909-4939</orcidid></search><sort><creationdate>20181010</creationdate><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><author>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>38/39</topic><topic>38/61</topic><topic>631/1647/48</topic><topic>631/337/2019</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Cell cycle</topic><topic>Chemotherapy</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Glioblastoma</topic><topic>Humanities and Social Sciences</topic><topic>Immune response</topic><topic>Medical prognosis</topic><topic>Molecular modelling</topic><topic>multidisciplinary</topic><topic>p53 Protein</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal transduction</topic><topic>Surgery</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>He, Dian</creatorcontrib><creatorcontrib>Yang, Pingrong</creatorcontrib><creatorcontrib>He, Junquan</creatorcontrib><creatorcontrib>Zhang, Yang</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Jing</au><au>He, Dian</au><au>Yang, Pingrong</au><au>He, Junquan</au><au>Zhang, Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genome-wide expression profiling of glioblastoma using a large combined cohort</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2018-10-10</date><risdate>2018</risdate><volume>8</volume><issue>1</issue><spage>15104</spage><epage>12</epage><pages>15104-12</pages><artnum>15104</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p &lt; 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>30305647</pmid><doi>10.1038/s41598-018-33323-z</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-4909-4939</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2018-10, Vol.8 (1), p.15104-12, Article 15104
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6180049
source Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 38/39
38/61
631/1647/48
631/337/2019
Brain cancer
Brain tumors
Cell cycle
Chemotherapy
Gene expression
Genomes
Glioblastoma
Humanities and Social Sciences
Immune response
Medical prognosis
Molecular modelling
multidisciplinary
p53 Protein
Patients
Prognosis
Science
Science (multidisciplinary)
Signal transduction
Surgery
Survival analysis
title Genome-wide expression profiling of glioblastoma using a large combined cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A25%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genome-wide%20expression%20profiling%20of%20glioblastoma%20using%20a%20large%20combined%20cohort&rft.jtitle=Scientific%20reports&rft.au=Tang,%20Jing&rft.date=2018-10-10&rft.volume=8&rft.issue=1&rft.spage=15104&rft.epage=12&rft.pages=15104-12&rft.artnum=15104&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-018-33323-z&rft_dat=%3Cproquest_pubme%3E2118311219%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2117920032&rft_id=info:pmid/30305647&rfr_iscdi=true